Five things to know:
1. As of mid-August, prescriptions for ivermectin have climbed to more than 88,000 per week, up from a pre-pandemic average of 3,600 per week, according to CDC data.
2. Despite federal warnings, some physicians are prescribing ivermectin to COVID-19 patients. However, not all hospitals agree with physicians’ prescriptions and are refusing to administer the drug, prompting patient lawsuits.
3. In Springfield, Ill., Memorial Medical Center won a court order to deny administering ivermectin to a COVID-19 patient on a ventilator, according to an Aug. 31 report in The State Journal-Register. A judge sided with Memorial Medical Center, which argued that ivermectin is an unproven treatment for COVID-19 and is potentially unsafe.
4. However, a court ordered a different Illinois hospital to administer the drug to a COVID-19 patient. Elmhurst (Ill.) Hospital administered ivermectin to a comatose COVID-19 patient May 3 after a judge’s order. The patient eventually was weaned off a ventilator, according to the Journal-Register.
5. A judge also ordered West Chester (Ohio) Hospital on Aug. 23 to administer the drug to a COVID-19 patient in the intensive care unit, according to the Ohio Capital Journal. The hospital will need to provide the patient with 30 milligrams of ivermectin each day for three weeks.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit